Here you can find a range of tools for research into, planning and evaluation of various aspects of immunization economics.
These tools aim to assist researchers in designing and implementing high quality costing studies.
This tool helps researchers develop cost-effective and efficient hierarchical clustered sample designs [EPIC Project and ProVac Initiative, 2019].
This toolkit provides guidance on sampling, survey instrument development and administration, and calculations for estimating the cost of routine immunization [ProVac Initiative].
This is a generic data collection template for costing routine immunization [EPIC project].
These are a set of data collection templates for immunization campaign costing studies. These include tools for facility, district, regional/state and national/federal levels. The facility and district tools also contain tabs for analyzing the data. Please refer to this user manual for guidance on modifying the tools [ICAN project, 2022].
The planning and evaluation tools can help inform decision makers on improving immunization delivery strategies and policies.
The National Immunization Strategy costing application (NIS.COST) can be used to estimate the costs and budgeting requirements of a National Immunization Strategy [UNICEF, 2022].
These Vaccine Cost Calculators allow users to assess and compare costs of certain vaccination programs over a period of 10 years with each vaccine product available in the global market. These Excel-based tools are available in multiple languages for rotavirus vaccines, pneumococcal conjugate vaccines, and human papillomavirus vaccines. [PATH, 2022]
The COVID-19 Vaccine Introduction and deployment Costing tool (CVIC tool) estimates the incremental costs of delivering COVID-19 vaccines [WHO, 2022].
This toolkit enables users to compare the level of vaccine coverage against the level of equity in a country and quantify the influence of key sociodemographic factors to inequity [VERSE project, 2022].
The UNIVAC tool is a single universal vaccine impact and cost-effectiveness decision support model. Input estimates of age-specific disease burden, age/dose-specific vaccine coverage, and effectiveness allow for a simple evaluation of direct vaccination impact on health outcomes [ProVac Initiative].
If you have any suggestions of further tools for this page, please send them to immunizationeconomics@thinkwell.global.
For many years, the Immunization Economics Community of Practice has supported researchers, policymakers, and practitioners around the world to use economic evidence to make better immunization decisions so that limited resources can save more lives.
Our work has been generously supported by the Gates Foundation and Gavi, the Vaccine Alliance, but our current funding ends this year. We are now seeking donations to help us bridge this transition and keep the community alive.
Donate